For the past 30 years Morningside Pharmaceuticals Ltd has been manufacturing and supplying quality generic and branded medicines to the UK and internationally.
In the United Kingdom, our licensed pharmaceutical products are distributed twice daily to NHS hospitals and pharmacies.
Globally, we are one of the leading medical suppliers to aid agencies, charities and NGOs – including UNICEF, the Red Cross, the World Health Organisation (WHO) and Medicines San Frontier (MSF), which is also known as Doctors Without Borders.
We also work with competent national authorities, internationally, to register our UK licensed Morningside products, as well as importers, distributors and wholesalers to bring them to market.
Our export success has been recognised by many awards including the UK’s most prestigious accolade – the Queen’s Award for Enterprise: International Trade.
Our innovative approach embraces challenges with heavy investment, including Research & Development and launching new niche generic molecules.
For both pharmacists and their patients the end result is greater choice.
Examples of new niche generic products launched, include:
Our unique strategy is to manage the entire end-to-end process from research & development, to registration, to sales, marketing and export within the Morningside companies.
This pioneering product development approach was recognised by winning the Pharmacy Business Award for Innovation in Generics in 2017. Morningside has also more recently won a LeicestershireLive Business Award for Excellence in Science & Technology in 2021, as well as the Investment category at the East Midlands Business Masters Awards in the same year.
Therapeutic areas our products cover: